LYRIC Polyclonal Antibody, Cy5.5 Conjugated from Bioss Inc.

Supplier Page

Supplier Page from
Bioss Inc. for
LYRIC Polyclonal Antibody, Cy5.5 Conjugated

Bioss Inc.'s LYRIC Polyclonal Antibody, Cy5.5 Conjugated is a Rabbit Polyclonal antibody. This antibody has been shown to work in applications such as: Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunohistochemistry - fixed, and Immunohistochemistry - frozen. The LYRIC Polyclonal Antibody, Cy5.5 Conjugated was generated using Metadherin, and MTDH as the antigen and it reacts with Human.

Description

Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF-kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance